ArticleBreast cancer research : BCR2015

MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.

Paul Vilquin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.